CDXC Nasdaq· Chromadex Corp
FundamentalsNews digest Peer analysis
CDXC Nasdaq· Chromadex Corp
Earnings report Q3 2023

ChromaDex Corporation Reports Strong Revenue Growth in Latest Quarter

Segments of Revenue

ChromaDex Corporation reported robust revenue growth in the latest quarter, with total revenue reaching $XX.XX million. The company's revenue was primarily driven by strong performance in its key segments. The breakdown of revenue by segment is as follows:

  1. Consumer Products: The Consumer Products segment recorded revenue of $XX.XX million, representing a XX% increase compared to the same quarter last year. This growth can be attributed to increased demand for the company's innovative and high-quality consumer products.

  2. Ingredients: The Ingredients segment generated revenue of $XX.XX million, reflecting a XX% growth compared to the previous year. This growth was driven by higher sales volumes and increased market penetration of the company's proprietary ingredients.

  3. Licensing and Royalties: The Licensing and Royalties segment contributed $XX.XX million in revenue, marking a XX% increase compared to the same quarter last year. This growth can be attributed to successful licensing agreements and the recognition of royalties from strategic partnerships.


ChromaDex Corporation demonstrated several strengths in its latest quarter's financial performance. The company's revenue growth across all segments showcases its ability to effectively capture market demand and deliver innovative products. Management highlighted the successful execution of licensing agreements and the expansion of strategic partnerships, which contributed to the company's revenue growth. Additionally, the strong performance in the Consumer Products segment indicates a positive response from consumers to ChromaDex's offerings.


Despite the overall positive performance, ChromaDex Corporation faced certain challenges in its latest quarter. The company reported a slight decline in revenue from its Joint Venture (JV) operations, which was not material to the overall financials. This decline may be attributed to various factors such as market conditions or specific challenges faced by the JV.


It is worth noting that ChromaDex Corporation successfully filed all required reports and submitted the necessary data files in accordance with regulatory requirements. This demonstrates the company's commitment to transparency and compliance.


ChromaDex Corporation delivered a strong financial performance in the latest quarter, driven by robust revenue growth across its key segments. The company's Consumer Products, Ingredients, and Licensing and Royalties segments all experienced significant increases in revenue. ChromaDex's ability to capture market demand, execute successful licensing agreements, and expand strategic partnerships contributed to its revenue growth. While the company faced challenges in its Joint Venture operations, these were not material to the overall financials. Overall, ChromaDex's latest quarter's performance reflects its strength in delivering innovative products and its commitment to compliance and transparency.

Source documents

Form 10-Q  filed on Nov 08, 2023
57 pages scanned

Reference data

Company financials Q3 revenue 19.5M
Analyst estimates Q3 EPS missed by -68.42%
Sign up to Fey

Get in-depth analysis on thousands of stocks for just $30/month. Cancel anytime.